https://www.europeanpharmaceuticalreview.com/news/185371/mhra-authorises-new-covid-19-vaccine/
0
0
8/2/23 at 9:20am
Organization
European Pharmaceutical Review
30 words
0
Comments
The new COVID-19 vaccine authorised by the MHRA contains an adjuvant and is indicated for patients over 16 years old.
You are the first to view
Create an account
or login to join the discussion